STTK
Shattuck Labs IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$427.28M
P/E Ratio
—
EPS
$-0.56
Beta
1.09
52W High
$8.33
52W Low
$0.71
50-Day MA
$6.41
200-Day MA
$4.04
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Shattuck Labs Inc
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapies for the treatment of cancer and autoimmune diseases in the United States. The company is headquartered in Austin, Texas.
Fundamentals
| Revenue (TTM) | $1.00M |
| Gross Profit (TTM) | $-2.98M |
| EBITDA | $-48.94M |
| Operating Margin | -5258.00% |
| Return on Equity | -61.00% |
| Return on Assets | -36.70% |
| Revenue/Share (TTM) | $0.01 |
| Book Value | $1.27 |
| Price-to-Book | 3.82 |
| Price-to-Sales (TTM) | 419.41 |
| EV/Revenue | 278.91 |
| EV/EBITDA | -3.62 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -66.60% |
| Shares Outstanding | $87.56M |
| Float | $47.71M |
| % Insiders | 5.26% |
| % Institutions | 73.20% |
Historical Volatility
HV 10-Day
156.46%
HV 20-Day
114.07%
HV 30-Day
101.78%
HV 60-Day
82.24%
HV Rank
73.0%
Volatility is currently expanding
Analyst Ratings
Consensus ($14.83 target)
2
Strong Buy5
Buy1
HoldMore HEALTHCARE Stocks
Data last updated: 6/13/2026